From Wikidoc - Reading time: 2 min| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C19H20N2O3 |
| Molar mass | 324.374 g/mol |
|
WikiDoc Resources for Ditazole |
|
Articles |
|---|
|
Most recent articles on Ditazole |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Ditazole at Clinical Trials.gov Clinical Trials on Ditazole at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Ditazole
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Ditazole Risk calculators and risk factors for Ditazole
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Ditazole |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Ditazole is a platelet aggregation inhibitor.It is marketed in Spain and Portugal under the trade name Ageroplas.[1]